CARVOLIX SA (CVX.PA) Fundamental Analysis & Valuation

EPA:CVX • FR0013333077

Current stock price

3.15 EUR
+0.05 (+1.61%)
Last:

This CVX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CVX.PA Profitability Analysis

1.1 Basic Checks

  • CVX had negative earnings in the past year.
  • In the past year CVX has reported a negative cash flow from operations.
  • CVX had negative earnings in each of the past 5 years.
  • CVX had a negative operating cash flow in each of the past 5 years.
CVX.PA Yearly Net Income VS EBIT VS OCF VS FCFCVX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • CVX's Return On Assets of -24.64% is on the low side compared to the rest of the industry. CVX is outperformed by 77.78% of its industry peers.
  • CVX's Return On Equity of -69.84% is on the low side compared to the rest of the industry. CVX is outperformed by 79.37% of its industry peers.
Industry RankSector Rank
ROA -24.64%
ROE -69.84%
ROIC N/A
ROA(3y)-25.74%
ROA(5y)-24.09%
ROE(3y)-47.78%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
CVX.PA Yearly ROA, ROE, ROICCVX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • CVX has a worse Gross Margin (1.34%) than 90.48% of its industry peers.
  • CVX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 1.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CVX.PA Yearly Profit, Operating, Gross MarginsCVX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CVX.PA Health Analysis

2.1 Basic Checks

  • CVX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CVX has been increased compared to 1 year ago.
  • Compared to 5 years ago, CVX has more shares outstanding
  • Compared to 1 year ago, CVX has an improved debt to assets ratio.
CVX.PA Yearly Shares OutstandingCVX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2019 2020 2021 2022 2023 2024 10M 20M 30M
CVX.PA Yearly Total Debt VS Total AssetsCVX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • CVX has an Altman-Z score of 0.59. This is a bad value and indicates that CVX is not financially healthy and even has some risk of bankruptcy.
  • CVX has a Altman-Z score of 0.59. This is in the lower half of the industry: CVX underperforms 74.60% of its industry peers.
  • A Debt/Equity ratio of 1.00 indicates that CVX is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.00, CVX is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.59
ROIC/WACCN/A
WACC7.71%
CVX.PA Yearly LT Debt VS Equity VS FCFCVX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.07 indicates that CVX should not have too much problems paying its short term obligations.
  • CVX's Current ratio of 1.07 is on the low side compared to the rest of the industry. CVX is outperformed by 71.43% of its industry peers.
  • A Quick Ratio of 1.07 indicates that CVX should not have too much problems paying its short term obligations.
  • CVX has a Quick ratio (1.07) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
CVX.PA Yearly Current Assets VS Current LiabilitesCVX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2019 2020 2021 2022 2023 2024 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CVX.PA Growth Analysis

3.1 Past

  • CVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.83%, which is quite impressive.
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, CVX will show a decrease in Earnings Per Share. The EPS will decrease by -1.24% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y4.12%
EPS Next 2Y-21.84%
EPS Next 3Y-1.24%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVX.PA Yearly Revenue VS EstimatesCVX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2024 2026 2027 2M 4M 6M 8M 10M
CVX.PA Yearly EPS VS EstimatesCVX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. CVX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • CVX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CVX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVX.PA Price Earnings VS Forward Price EarningsCVX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVX.PA Per share dataCVX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.84%
EPS Next 3Y-1.24%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CVX.PA Dividend Analysis

5.1 Amount

  • CVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CVX.PA Fundamentals: All Metrics, Ratios and Statistics

CARVOLIX SA

EPA:CVX (4/14/2026, 7:00:00 PM)

3.15

+0.05 (+1.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-02
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.66%
Ins Owner ChangeN/A
Market Cap186.61M
Revenue(TTM)4.12M
Net Income(TTM)-14.74M
Analysts85
Price Target4.39 (39.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.17%
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)8.82%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 45.31
P/FCF N/A
P/OCF N/A
P/B 8.84
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.73
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.07
BVpS0.36
TBVpS-0.43
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -24.64%
ROE -69.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 1.34%
FCFM N/A
ROA(3y)-25.74%
ROA(5y)-24.09%
ROE(3y)-47.78%
ROE(5y)-43.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.85%
Cap/Sales 4.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 0.59
F-Score5
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)6.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.63%
EPS Next Y4.12%
EPS Next 2Y-21.84%
EPS Next 3Y-1.24%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year12.11%
EBIT Next 3Y-22.71%
EBIT Next 5YN/A
FCF growth 1Y-9.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.51%
OCF growth 3YN/A
OCF growth 5YN/A

CARVOLIX SA / CVX.PA Fundamental Analysis FAQ

What is the fundamental rating for CVX stock?

ChartMill assigns a fundamental rating of 1 / 10 to CVX.PA.


Can you provide the valuation status for CARVOLIX SA?

ChartMill assigns a valuation rating of 0 / 10 to CARVOLIX SA (CVX.PA). This can be considered as Overvalued.


How profitable is CARVOLIX SA (CVX.PA) stock?

CARVOLIX SA (CVX.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for CVX stock?

The financial health rating of CARVOLIX SA (CVX.PA) is 2 / 10.